RELB |
RELB: Transcription factor RelB |
PIAS4 |
PIAS4, PIASG: E3 SUMO-protein ligase PIAS4 |
2.812 |
Evidence |
|
HMGB3 |
HMGB3, HMG2A, HMG4: High mobility group protein B3 |
RELB |
RELB: Transcription factor RelB |
2.812 |
Evidence |
|
CCND1 |
CCND1, BCL1, PRAD1: G1/S-specific cyclin-D1 |
NR1H2 |
NR1H2, LXRB, NER, UNR: Oxysterols receptor LXR-beta |
2.812 |
Evidence |
|
NCOA2 |
NCOA2, TIF2: Nuclear receptor coactivator 2 |
GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
2.812 |
Evidence |
|
PRKD3 |
PRKD3, EPK2, PRKCN: Serine/threonine-protein kinase D3 |
PDLIM5 |
PDLIM5, ENH: PDZ and LIM domain protein 5 |
2.812 |
Evidence |
|
PRKCH |
PRKCH, PKCL, PRKCL: Protein kinase C eta type |
TAGLN2 |
TAGLN2, RP11-48O20.1-003, hCG_39730: TAGLN2 protein |
2.812 |
Evidence |
|
GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
ING2 |
ING2, ING1L: Inhibitor of growth protein 2 |
2.812 |
Evidence |
|
SLC2A14 |
SLC2A3, GLUT3: Solute carrier family 2, facilitated glucose transporter member 3 |
AKT1 |
AKT1, PKB, RAC: RAC-alpha serine/threonine-protein kinase |
2.807 |
Evidence |
|
ADRB2 |
ADRB2, ADRB2R, B2AR: Beta-2 adrenergic receptor |
NPR2 |
NPR2, ANPRB: Atrial natriuretic peptide receptor B precursor |
2.805 |
Evidence |
|
FRS3 |
FRS3: Fibroblast growth factor receptor substrate 3 |
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
2.805 |
Evidence |
|
AQP2 |
AQP2: Aquaporin-2 |
SYK |
SYK: Tyrosine-protein kinase SYK |
2.805 |
Evidence |
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
AQP2 |
AQP2: Aquaporin-2 |
2.805 |
Evidence |
|
AQP2 |
AQP2: Aquaporin-2 |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
2.805 |
Evidence |
|
FOS |
FOS, G0S7: Proto-oncogene protein c-fos |
SALL1 |
SALL1, SAL1: Sal-like protein 1 |
2.805 |
Evidence |
|
TUBA1 |
TUBA4A, TUBA1: Tubulin alpha-4A chain |
PAK7 |
PAK7, KIAA1264, PAK5: Serine/threonine-protein kinase PAK 7 |
2.805 |
Evidence |
|
SLC4A1 |
SLC4A1, AE1, DI, EPB3: Band 3 anion transport protein |
CSF1R |
CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor |
2.805 |
Evidence |
|
HTR2C |
HTR2C, HTR1C: 5-hydroxytryptamine receptor 2C |
CCR4 |
CCR4, CMKBR4: C-C chemokine receptor type 4 |
2.805 |
Evidence |
|
CTRB1 |
CTRB1, CTRB: Chymotrypsinogen B precursor |
C6 |
C6: Complement component C6 precursor |
2.805 |
Evidence |
|
LEFTY1 |
LEFTY1, LEFTB, UNQ278/PRO317, LEFTYB: Left-right determination factor 1 precurso |
INHBC |
INHBC: Inhibin beta C chain precursor |
2.805 |
Evidence |
|
PIK3R4 |
PIK3R4: Phosphoinositide 3-kinase regulatory subunit 4 |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
2.805 |
Evidence |
|
SYK |
SYK: Tyrosine-protein kinase SYK |
ARHGEF7 |
ARHGEF7, COOL1, KIAA0142, P85SPR, PAK3BP, PIXB: Rho guanine nucleotide exchange |
2.805 |
Evidence |
|
CDH3 |
CDH3, CDHP: Cadherin-3 precursor |
DSC2 |
DSC2, DSC3: Desmocollin-2 precursor |
2.805 |
Evidence |
|
RB1 |
RB1: Retinoblastoma-associated protein |
POLR3F |
POLR3F: DNA-directed RNA polymerase III subunit RPC6 |
2.805 |
Evidence |
|
SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
SOCS1 |
SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 |
2.805 |
Evidence |
|
FADD |
FADD, MORT1: Protein FADD |
RNF130 |
RNF130: Goliath homolog precursor |
2.805 |
Evidence |
|